BCP
WGSWW

Berylson Capital Partners’s GeneDx Holdings Warrant WGSWW Stock Holding History

Berylson Capital Partners’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$24.9K Hold
333,333
– – 0.06% 21
2024
Q2 		$9.9K Hold
333,333
– – 0.03% 20
2024
Q1 		$18.3K Hold
333,333
– – 0.04% 24
2023
Q4 		$3.33K Hold
333,333
– – 0.01% 27
2023
Q3 		$9.97K Hold
333,333
– – 0.03% 26
2023
Q2 		$3.43K Hold
333,333
– – 0.01% 21
2023
Q1 		$6.17K Buy
+333,333
New +$7.93K 0.02% 20

Other funds holding WGSWW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Berylson Capital Partners's WGSWW Position: Q1 2023 in Review

Berylson Capital Partners sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2023, closing a stake of 333,333 shares — an estimated $7.93K sold.

Berylson Capital Partners first reported a position in WGSWW in Q3 2021 and held it in 6 quarters. The position peaked at $707K in Q3 2021. 21 funds tracked by Wall St. Rank hold WGSWW as of Q1 2023.

  • Berylson Capital Partners reported no remaining GeneDx Holdings Warrant position as of Q1 2023 after selling out during the quarter.
  • Berylson Capital Partners sold 333,333 GeneDx Holdings Warrant shares in Q1 2023, an estimated $7.93K.
  • Berylson Capital Partners first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 6 quarters.
  • Berylson Capital Partners's GeneDx Holdings Warrant position peaked at $707K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2023.

Based on Berylson Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.